{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:56:23Z","timestamp":1794855383924,"version":"4.9.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Boehringer Ingelheim Veterinary Medicine Belgium"},{"name":"Flemish Agency for Innovation and Entrepreneurship","award":["HBC.2019.2343"],"award-info":[{"award-number":["HBC.2019.2343"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>As current therapies for canine osteoarthritis (OA) provide mainly symptomatic improvement and fail to address the complex pathology of the disease, mesenchymal stem cells (MSCs) offer a promising biological approach to address both aspects of OA through their immunomodulatory properties.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study aimed to investigate the safety and efficacy of xenogeneic MSCs in dogs with OA at different dose levels after intravenous injection. OA was surgically induced in the right stifle joint. Thirty-two male and female dogs were divided into three treatment groups and a control group. Regular general physical examinations; lameness, joint, radiographic, and animal caretaker assessments; pressure plate analyses; and blood analyses were performed over 42 days. At study end, joint tissues were evaluated regarding gross pathology, histopathology, and immunohistochemistry. In a follow-up study, the biodistribution of intravenously injected<jats:sup>99m<\/jats:sup>Tc-labeled equine peripheral blood-derived MSCs was evaluated over 24h in three dogs after the cruciate ligament section.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The dose determination study showed the systemic administration of ePB-MSCs in a canine OA model resulted in an analgesic, anti-inflammatory, and joint tissue protective effect associated with improved clinical signs and improved cartilage structure, as well as a good safety profile. Furthermore, a clear dose effect was found with 0.3 \u00d7 10<jats:sup>6<\/jats:sup>ePB-MSCs as the most effective dose. In addition, this treatment was demonstrated to home specifically towards the injury zone in a biodistribution study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This model-based study is the first to confirm the efficacy and safety of systemically administered xenogeneic MSCs in dogs with OA. The systemic administration of a low dose of xenogeneic MSCs could offer a widely accessible, safe, and efficacious treatment to address the complex pathology of canine OA and potentially slow down the disease progression by its joint tissue protective effect.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13075-023-03168-7","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T06:02:21Z","timestamp":1696312941000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Low-dose xenogeneic mesenchymal stem cells target canine osteoarthritis through systemic immunomodulation and homing"],"prefix":"10.1186","volume":"25","author":[{"given":"Charlotte","family":"Beerts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Y.","family":"Broeckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Depuydt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesa","family":"Tack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lore","family":"Van Hecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Chiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Van Brantegem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Hellmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"de Bouvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Van Bruaene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine","family":"De Ryck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Duchateau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Van Ryssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathelijne","family":"Peremans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy H.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Verhoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Pauwelyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan H.","family":"Spaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,3]]},"reference":[{"issue":"3","key":"3168_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1067\/mgn.2001.116375","volume":"22","author":"PC Birchfield","year":"2001","unstructured":"Birchfield PC. Osteoarthritis overview. Geriatr Nurs (Minneap). 2001;22(3):124\u201331.","journal-title":"Geriatr Nurs (Minneap)."},{"issue":"5","key":"3168_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41584-019-0202-1","volume":"15","author":"RL Meeson","year":"2019","unstructured":"Meeson RL, Todhunter RJ, Blunn G, Nuki G, Pitsillides AA. Spontaneous dog osteoarthritis\u2014a One Medicine vision. Nat Rev Rheumatol. 2019;15(5):273\u201387.","journal-title":"Nat Rev Rheumatol."},{"key":"3168_CR3","doi-asserted-by":"crossref","unstructured":"Johnston SA. Osteoarthritis. Joint anatomy, physiology, and pathobiology. Vet Clin North Am Small Anim Pract. 1997;27(4):699\u2013723.","DOI":"10.1016\/S0195-5616(97)50076-3"},{"issue":"1","key":"3168_CR4","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.1038\/s41598-018-23940-z","volume":"8","author":"KL Anderson","year":"2018","unstructured":"Anderson KL, O\u2019Neill DG, Brodbelt DC, Church DB, Meeson RL, Sargan D, et al. Prevalence, duration and risk factors for appendicular osteoarthritis in a UK dog population under primary veterinary care. Sci Rep. 2018;8(1):5641.","journal-title":"Sci Rep."},{"issue":"8","key":"3168_CR5","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/jsap.13500","volume":"63","author":"A Wright","year":"2022","unstructured":"Wright A, Amodie DM, Cernicchiaro N, Lascelles BDX, Pavlock AM, Roberts C, et al. Identification of canine osteoarthritis using an owner-reported questionnaire and treatment monitoring using functional mobility tests. J Small Anim Pract. 2022;63(8):609\u201318.","journal-title":"J Small Anim Pract."},{"issue":"1","key":"3168_CR6","first-page":"49","volume":"85","author":"K Sinusas","year":"2012","unstructured":"Sinusas K. Osteoarthritis: diagnosis and treatment. Am Fam Physician. 2012;85(1):49\u201356.","journal-title":"Am Fam Physician."},{"key":"3168_CR7","first-page":"89","volume":"9","author":"L Kong","year":"2017","unstructured":"Kong L, Zheng L-Z, Qin L, Ho KKW. Role of mesenchymal stem cells in osteoarthritis treatment. J Orthop Transl. 2017;9:89\u2013103.","journal-title":"J Orthop Transl."},{"issue":"11","key":"3168_CR8","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1016\/j.joca.2015.07.004","volume":"23","author":"Y-M Pers","year":"2015","unstructured":"Pers Y-M, Ruiz M, No\u00ebl D, Jorgensen C. Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art and perspectives. Osteoarthr Cartil. 2015;23(11):2027\u201335.","journal-title":"Osteoarthr Cartil."},{"issue":"1","key":"3168_CR9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12891-016-1085-9","volume":"17","author":"J Freitag","year":"2016","unstructured":"Freitag J, Bates D, Boyd R, Shah K, Barnard A, Huguenin L, et al. Mesenchymal stem cell therapy in the treatment of osteoarthritis: reparative pathways, safety and efficacy \u2013 a review. BMC Musculoskelet Disord. 2016;17(1):230.","journal-title":"BMC Musculoskelet Disord."},{"issue":"4","key":"3168_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/scrt116","volume":"3","author":"PK Gupta","year":"2012","unstructured":"Gupta PK, Das AK, Chullikana A, Majumdar AS. Mesenchymal stem cells for cartilage repair in osteoarthritis. Stem Cell Res Ther. 2012;3(4):25.","journal-title":"Stem Cell Res Ther."},{"issue":"5","key":"3168_CR11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.4252\/wjsc.v11.i5.254","volume":"11","author":"A Sasaki","year":"2019","unstructured":"Sasaki A, Mizuno M, Mochizuki M, Sekiya I. Mesenchymal stem cells for cartilage regeneration in dogs. World J Stem Cells. 2019;11(5):254\u201369.","journal-title":"World J Stem Cells."},{"key":"3168_CR12","doi-asserted-by":"crossref","unstructured":"Brondeel C, Pauwelyn G, Bakker E De, Saunders J, Samoy Y. Review: mesenchymal stem cell therapy in canine osteoarthritis research : \u201cExperientia Docet\u201d (Experience Will Teach Us). Front Vet Sci. 2021;8:1\u201313.","DOI":"10.3389\/fvets.2021.668881"},{"issue":"2","key":"3168_CR13","first-page":"448","volume":"13","author":"C Zhu","year":"2021","unstructured":"Zhu C, Wu W, Qu X. Mesenchymal stem cells in osteoarthritis therapy: a review. Am J Transl Res. 2021;13(2):448\u201361.","journal-title":"Am J Transl Res."},{"issue":"10","key":"3168_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047559","volume":"7","author":"MM Lalu","year":"2012","unstructured":"Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One. 2012;7(10): e47559.","journal-title":"PLoS One."},{"issue":"20","key":"3168_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.21037\/atm.2018.09.55","volume":"6","author":"T Xia","year":"2018","unstructured":"Xia T, Yu F, Zhang K, Wu Z, Shi D, Teng H, et al. The effectiveness of allogeneic mesenchymal stem cells therapy for knee osteoarthritis in pigs. Ann Transl Med. 2018;6(20):404.","journal-title":"Ann Transl Med."},{"key":"3168_CR16","doi-asserted-by":"crossref","unstructured":"Vega A, Mart\u00edn-Ferrero MA, Del Canto F, Alberca M, Garc\u00eda V, Munar A, et al. Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial. Transplantation. 2015;99(8).","DOI":"10.1097\/TP.0000000000000678"},{"issue":"3","key":"3168_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1055\/s-0039-1678547","volume":"32","author":"A Olsen","year":"2019","unstructured":"Olsen A, Johnson V, Webb T, Santangelo KS, Dow S, Duerr FM. Evaluation of intravenously delivered allogeneic mesenchymal stem cells for treatment of elbow osteoarthritis in dogs: a pilot study. Vet Comp Orthop Traumatol. 2019;32(3):173\u201381.","journal-title":"Vet Comp Orthop Traumatol."},{"issue":"8","key":"3168_CR18","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1164\/rccm.201001-0010OC","volume":"182","author":"SHJ Mei","year":"2010","unstructured":"Mei SHJ, Haitsma JJ, Dos Santos CC, Deng Y, Lai PFH, Slutsky AS, et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med. 2010;182(8):1047\u201357.","journal-title":"Am J Respir Crit Care Med."},{"key":"3168_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/4587594","volume":"2019","author":"R Daems","year":"2019","unstructured":"Daems R, Van Hecke L, Schwarzkopf I, Depuydt E, Broeckx SY, David M, et al. A Feasibility study on the use of equine chondrogenic induced mesenchymal stem cells as a treatment for natural occurring osteoarthritis in dogs. Stem Cells Int. 2019;2019:1\u201311.","journal-title":"Stem Cells Int."},{"issue":"3","key":"3168_CR20","doi-asserted-by":"publisher","first-page":"196","DOI":"10.5500\/wjt.v4.i3.196","volume":"4","author":"S-Y Tsai","year":"2014","unstructured":"Tsai S-Y. Intra-articular transplantation of porcine adipose-derived stem cells for the treatment of canine osteoarthritis: a pilot study. World J Transplant. 2014;4(3):196.","journal-title":"World J Transplant."},{"issue":"1","key":"3168_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-021-02457-9","volume":"12","author":"C Beerts","year":"2021","unstructured":"Beerts C, Brondeel C, Pauwelyn G, Depuydt E, Tack L, Duchateau L, et al. Scintigraphic tracking of 99mTechnetium-labelled equine peripheral blood-derived mesenchymal stem cells after intravenous, intramuscular, and subcutaneous injection in healthy dogs. Stem Cell Res Ther. 2021;12(1):1\u201311.","journal-title":"Stem Cell Res Ther."},{"issue":"2","key":"3168_CR22","doi-asserted-by":"publisher","first-page":"E38","DOI":"10.1002\/ccd.25566","volume":"86","author":"SJ Hong","year":"2015","unstructured":"Hong SJ, Rogers PI, Kihlken J, Warfel J, Bull C, Deuter-Reinhard M, et al. Intravenous xenogeneic transplantation of human adipose-derived stem cells improves left ventricular function and microvascular integrity in swine myocardial infarction model. Catheter Cardiovasc Interv. 2015;86(2):E38-48.","journal-title":"Catheter Cardiovasc Interv."},{"issue":"5","key":"3168_CR23","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/jbcr\/irab094","volume":"42","author":"TC Heard","year":"2021","unstructured":"Heard TC, G\u00f3mez BI, Saathoff ME, Duarte J, Dubick MA, Bynum JA, et al. Minimal effects of intravenous administration of xenogeneic adipose derived stem cells on organ function in a porcine 40% TBSA burn model. J Burn Care Res. 2021;42(5):870\u20139.","journal-title":"J Burn Care Res."},{"issue":"8","key":"3168_CR24","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00277-011-1156-9","volume":"90","author":"Y Li","year":"2011","unstructured":"Li Y, Qu Y, Wu Y, Wang X, Wei J, Huang W, et al. Bone marrow mesenchymal stem cells reduce the antitumor activity of cytokine-induced killer\/natural killer cells in K562 NOD\/SCID mice. Ann Hematol. 2011;90(8):873\u201385.","journal-title":"Ann Hematol."},{"key":"3168_CR25","doi-asserted-by":"crossref","unstructured":"Mouiseddine M, Fran\u00e7ois S, Souidi M, Chapel A. Intravenous human mesenchymal stem cells transplantation in NOD\/SCID mice preserve liver integrity of irradiation damage. Methods in Molecular Biology - Liver stem cells Methods and protocols. 2012;179\u201388.","DOI":"10.1007\/978-1-61779-468-1_15"},{"issue":"1\u20132","key":"3168_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cca.2008.12.022","volume":"402","author":"MJ Paik","year":"2009","unstructured":"Paik MJ, Li WY, Ahn YH, Lee PH, Choi S, Kim KR, et al. The free fatty acid metabolome in cerebral ischemia following human mesenchymal stem cell transplantation in rats. Clin Chim Acta. 2009;402(1\u20132):25\u201330.","journal-title":"Clin Chim Acta."},{"issue":"5","key":"3168_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/xen.12000","volume":"19","author":"J Li","year":"2012","unstructured":"Li J, Ezzelarab M, Cooper D. Do mesenchymal stem cells function across species. Xenotransplantation. 2012;19(5):273\u201385.","journal-title":"Xenotransplantation."},{"issue":"1","key":"3168_CR28","first-page":"1","volume":"2","author":"A Bertolo","year":"2015","unstructured":"Bertolo A, Schlaefli P, Malonzo-Marty C, Baur M, P\u00f6tzel T, Steffen F, et al. Comparative characterization of canine and human mesenchymal stem cells derived from bone marrow. Int J Stem cell Res Ther. 2015;2(1):1\u20136.","journal-title":"Int J Stem cell Res Ther."},{"issue":"10","key":"3168_CR29","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.3727\/096368914X685294","volume":"24","author":"A Bertolo","year":"2015","unstructured":"Bertolo A, Steffen F, Malonzo-Marty C, Stoyanov J. Canine mesenchymal stem cell potential and the importance of dog breed: implication for cell-based therapies. Cell Transplant. 2015;24(10):1969\u201380.","journal-title":"Cell Transplant."},{"issue":"1","key":"3168_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.tvjl.2012.05.006","volume":"195","author":"JH Spaas","year":"2013","unstructured":"Spaas JH, De Schauwer C, Cornillie P, Meyer E, Van Soom A, Van de Walle GR. Culture and characterisation of equine peripheral blood mesenchymal stromal cells. Vet J. 2013;195(1):107\u201313.","journal-title":"Vet J."},{"issue":"1","key":"3168_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13018-016-0346-5","volume":"11","author":"EL Kuyinu","year":"2016","unstructured":"Kuyinu EL, Narayanan G, Nair LS, Laurencin CT. Animal models of osteoarthritis: classification, update, and measurement of outcomes. J Orthop Surg Res. 2016;11(1):19.","journal-title":"J Orthop Surg Res."},{"issue":"2","key":"3168_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/joca.2001.0491","volume":"10","author":"ACA Marijnissen","year":"2002","unstructured":"Marijnissen ACA, van Roermund PM, TeKoppele JM, Bijlsma JWJ, Lafeber FPJG. The canine \u2018groove\u2019 model, compared with the ACLT model of osteoarthritis. Osteoarthr Cartil. 2002;10(2):145\u201355.","journal-title":"Osteoarthr Cartil."},{"issue":"4","key":"3168_CR33","first-page":"191","volume":"14","author":"NV Goranov","year":"2011","unstructured":"Goranov NV. Experimental osteoarthritis models in veterinary medicine - relevance, potential and challenges. Bulg J Vet Med. 2011;14(4):191\u2013200.","journal-title":"Bulg J Vet Med."},{"key":"3168_CR34","doi-asserted-by":"crossref","unstructured":"Marijnissen ACA, van Roermund PM, Verzijl N, Tekoppele JM, Bijlsma JWJ, Lafeber FPJG. Steady progression of osteoarthritic features in the canine groove model. Osteoarthr Cartil. 2002;10(4):282\u20139. 72.","DOI":"10.1053\/joca.2001.0507"},{"issue":"1","key":"3168_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.joca.2004.07.009","volume":"14","author":"SC Mastbergen","year":"2006","unstructured":"Mastbergen SC, Marijnissen AC, Vianen ME, van Roermund PM, Bijlsma JW, Lafeber FP. The canine \u2018groove\u2019 model of osteoarthritis is more than simply the expression of surgically applied damage. Osteoarthr Cartil. 2006;14(1):39\u201346.","journal-title":"Osteoarthr Cartil."},{"issue":"9","key":"3168_CR36","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.joca.2009.03.015","volume":"17","author":"JR Connor","year":"2009","unstructured":"Connor JR, LePage C, Swift BA, Yamashita D, Bendele AM, Maul D, et al. Protective effects of a cathepsin K inhibitor, SB-553484, in the canine partial medial meniscectomy model of osteoarthritis. Osteoarthr Cartil. 2009;17(9):1236\u201343.","journal-title":"Osteoarthr Cartil."},{"key":"3168_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2157-7552.S11-001","volume":"S11","author":"S Broeckx","year":"2012","unstructured":"Broeckx S. Tenogenesis of equine peripheral blood-derived mesenchymal stem cells: in vitro versus in vivo. J Tissue Sci Eng. 2012;S11:1\u20136.","journal-title":"J Tissue Sci Eng."},{"key":"3168_CR38","volume-title":"Shave SL","author":"NG Robinson","year":"2008","unstructured":"Robinson NG. Shave SL. Canine chronic pain scale: Color State Univ Vet Med Cent; 2008."},{"issue":"11","key":"3168_CR39","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1136\/vr.102397","volume":"176","author":"M Payne-Johnson","year":"2015","unstructured":"Payne-Johnson M, Becskei C, Chaudhry Y, Stegemann MR. Comparative efficacy and safety of mavacoxib and carprofen in the treatment of canine osteoarthritis. Vet Rec. 2015;176(11):284.","journal-title":"Vet Rec."},{"issue":"7","key":"3168_CR40","doi-asserted-by":"publisher","first-page":"979","DOI":"10.2460\/ajvr.2002.63.979","volume":"63","author":"G Jaegger","year":"2002","unstructured":"Jaegger G, Marcellin-Little DJ, Levine D. Reliability of goniometry in Labrador Retrievers. Am J Vet Res. 2002;63(7):979\u201386.","journal-title":"Am J Vet Res."},{"issue":"6","key":"3168_CR41","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3415\/VCOT-16-09-0134","volume":"30","author":"M Wessely","year":"2017","unstructured":"Wessely M, Br\u00fchschwein A, Schnabl-Feichter E. Evaluation of intra- and inter-observer measurement variability of a radiographic stifle osteoarthritis scoring system in dogs. Vet Comp Orthop Traumatol. 2017;30(6):377\u201384.","journal-title":"Vet Comp Orthop Traumatol."},{"issue":"6","key":"3168_CR42","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2460\/ajvr.68.6.631","volume":"68","author":"DC Brown","year":"2007","unstructured":"Brown DC, Boston RC, Coyne JC, Farrar JT. Development and psychometric testing of an instrument designed to measure chronic pain in dogs with osteoarthritis. Am J Vet Res. 2007;68(6):631\u20137.","journal-title":"Am J Vet Res."},{"key":"3168_CR43","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.1016\/j.joca.2010.04.017","volume":"18","author":"JL Cook","year":"2010","unstructured":"Cook JL, Kuroki K, Visco D, Pelletier J-P, Schulz L, Lafeber FPJG. The OARSI histopathology initiative \u2013 recommendations for histological assessments of osteoarthritis in the dog. Osteoarthr Cartil. 2010;18:S66-79.","journal-title":"Osteoarthr Cartil."},{"issue":"7","key":"3168_CR44","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1177\/0963689719837897","volume":"28","author":"A Musia\u0142-Wysocka","year":"2019","unstructured":"Musia\u0142-Wysocka A, Kot M, Majka M. The pros and cons of mesenchymal stem cell-based therapies. Cell Transplant. 2019;28(7):801\u201312.","journal-title":"Cell Transplant."},{"issue":"1","key":"3168_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12917-018-1413-4","volume":"14","author":"AJ Villatoro","year":"2018","unstructured":"Villatoro AJ, Claros S, Fern\u00e1ndez V, Alcoholado C, Fari\u00f1as F, Moreno A, et al. Safety and efficacy of the mesenchymal stem cell in feline eosinophilic keratitis treatment. BMC Vet Res. 2018;14(1):1\u201313.","journal-title":"BMC Vet Res."},{"issue":"3","key":"3168_CR46","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.tvjl.2015.07.023","volume":"206","author":"EM P\u00e9rez-Merino","year":"2015","unstructured":"P\u00e9rez-Merino EM, Us\u00f3n-Casa\u00fas JM, Duque-Carrasco J, Zaragoza-Bayle C, Mari\u00f1as-Pardo L, Hermida-Prieto M, et al. Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: endoscopic and histological outcomes. Vet J. 2015;206(3):391\u20137.","journal-title":"Vet J."},{"issue":"1","key":"3168_CR47","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s13287-015-0236-5","volume":"6","author":"Y Kim","year":"2015","unstructured":"Kim Y, Jo S, Kim WH, Kweon O-K. Antioxidant and anti-inflammatory effects of intravenously injected adipose derived mesenchymal stem cells in dogs with acute spinal cord injury. Stem Cell Res Ther. 2015;6(1):229.","journal-title":"Stem Cell Res Ther."},{"issue":"1\u20132","key":"3168_CR48","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.vetimm.2013.09.003","volume":"156","author":"JH Pigott","year":"2013","unstructured":"Pigott JH, Ishihara A, Wellman ML, Russell DS, Bertone AL. Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses. Vet Immunol Immunopathol. 2013;156(1\u20132):99\u2013106.","journal-title":"Vet Immunol Immunopathol."},{"issue":"4","key":"3168_CR49","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/evj.12647","volume":"49","author":"AK Berglund","year":"2017","unstructured":"Berglund AK, Schnabel LV. Allogeneic major histocompatibility complex-mismatched equine bone marrow-derived mesenchymal stem cells are targeted for death by cytotoxic anti-major histocompatibility complex antibodies. Equine Vet J. 2017;49(4):539\u201344.","journal-title":"Equine Vet J."},{"issue":"1","key":"3168_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-015-0053-x","volume":"6","author":"LM Pezzanite","year":"2015","unstructured":"Pezzanite LM, Fortier LA, Antczak DF, Cassano JM, Brosnahan MM, Miller D, et al. Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo. Stem Cell Res Ther. 2015;6(1):1\u201311.","journal-title":"Stem Cell Res Ther."},{"key":"3168_CR51","doi-asserted-by":"crossref","unstructured":"Harman R, Carlson K, Gaynor J, Gustafson S, Dhupa S, Clement K, et al. A prospective, randomized, masked, and placebo-controlled efficacy study of intraarticular allogeneic adipose stem cells for the treatment of osteoarthritis in dogs. Front Vet Sci. 2016;3.","DOI":"10.3389\/fvets.2016.00081"},{"issue":"2018","key":"3168_CR52","first-page":"1","volume":"28","author":"K Shah","year":"2018","unstructured":"Shah K, Drury T, Roic I, Hansen P, Malin M, Boyd R, et al. Outcome of allogeneic adult stem cell therapy in dogs suffering from osteoarthritis and other joint defects. Stem Cells Int. 2018;28(2018):1\u20137.","journal-title":"Stem Cells Int."},{"key":"3168_CR53","first-page":"1","volume":"2018","author":"B Zhang","year":"2018","unstructured":"Zhang B, Wang B, Li S, Luo D, Zhan X, Chen S, et al. Evaluation of the curative effect of umbilical cord mesenchymal stem cell therapy for knee arthritis in dogs using imaging technology. Stem Cells Int. 2018;2018:1\u201312.","journal-title":"Stem Cells Int."},{"key":"3168_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fvets.2016.00081","volume":"3","author":"R Harman","year":"2016","unstructured":"Harman R, Carlson K, Gaynor J, Gustafson S, Dhupa S, Clement K, et al. A prospective, randomized, masked, and placebo-controlled efficacy study of intraarticular allogeneic adipose stem cells for the treatment of osteoarthritis in dogs. Front Vet Sci. 2016;3:1\u201310.","journal-title":"Front Vet Sci."},{"key":"3168_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fvets.2019.00474","volume":"6","author":"SE Kim","year":"2019","unstructured":"Kim SE, Pozzi A, Yeh JC, Lopez-Velazquez M, Au Yong JA, Townsend S, et al. Intra-articular umbilical cord derived mesenchymal stem cell therapy for chronic elbow osteoarthritis in dogs: a double-blinded, placebo-controlled clinical trial. Front Vet Sci. 2019;6:1\u201310.","journal-title":"Front Vet Sci."},{"key":"3168_CR56","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fvets.2019.00010","volume":"6","author":"Q Cabon","year":"2019","unstructured":"Cabon Q, Febre M, Gomez N, Cachon T, Pillard P, Carozzo C, et al. Long-term safety and efficacy of single or repeated intra-articular injection of allogeneic neonatal mesenchymal stromal cells for managing pain and lameness in moderate to severe canine osteoarthritis without anti-inflammatory pharmacological support: pi. Front Vet Sci. 2019;6:10.","journal-title":"Front Vet Sci."},{"issue":"1","key":"3168_CR57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/JMAU.JMAU_2_20","volume":"9","author":"A Mostafa","year":"2020","unstructured":"Mostafa A, Korayem HE, Fekry E, Hosny S. The effect of intra-articular versus intravenous injection of mesenchymal stem cells on experimentally-induced knee joint osteoarthritis. J Microsc Ultrastruct. 2020;9(1):31\u20138.","journal-title":"J Microsc Ultrastruct."},{"issue":"2","key":"3168_CR58","first-page":"275","volume":"29","author":"A Mokbel","year":"2011","unstructured":"Mokbel A, El-Tookhy O, Shamaa AA, Sabry D, Rashed L, Mostafa A. Homing and efficacy of intra-articular injection of autologous mesenchymal stem cells in experimental chondral defects in dogs. Clin Exp Rheumatol. 2011;29(2):275\u201384.","journal-title":"Clin Exp Rheumatol."},{"issue":"1","key":"3168_CR59","doi-asserted-by":"publisher","first-page":"9900","DOI":"10.1038\/s41598-018-27737-y","volume":"8","author":"L Li","year":"2018","unstructured":"Li L, Duan X, Fan Z, Chen L, Xing F, Xu Z, et al. Mesenchymal stem cells in combination with hyaluronic acid for articular cartilage defects. Sci Rep. 2018;8(1):9900.","journal-title":"Sci Rep."},{"issue":"2","key":"3168_CR60","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1302\/2046-3758.62.BJR-2016-0188.R1","volume":"6","author":"D Kazemi","year":"2017","unstructured":"Kazemi D, Shams Asenjan K, Dehdilani N, Parsa H. Canine articular cartilage regeneration using mesenchymal stem cells seeded on platelet rich fibrin. Bone Joint Res. 2017;6(2):98\u2013107.","journal-title":"Bone Joint Res."},{"issue":"7","key":"3168_CR61","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1016\/j.msec.2013.05.040","volume":"33","author":"X Duan","year":"2013","unstructured":"Duan X, Zhu X, Dong X, Yang J, Huang F, Cen S, et al. Repair of large osteochondral defects in a beagle model with a novel type I collagen\/glycosaminoglycan-porous titanium biphasic scaffold. Mater Sci Eng C. 2013;33(7):3951\u20137.","journal-title":"Mater Sci Eng C."},{"issue":"1","key":"3168_CR62","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.arthro.2018.07.028","volume":"35","author":"C-W Ha","year":"2019","unstructured":"Ha C-W, Park Y-B, Kim SH, Lee H-J. Intra-articular mesenchymal stem cells in osteoarthritis of the knee: a systematic review of clinical outcomes and evidence of cartilage repair. Arthrosc J Arthrosc Relat Surg. 2019;35(1):277-288.e2.","journal-title":"Arthrosc J Arthrosc Relat Surg."},{"issue":"2","key":"3168_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0149472","volume":"11","author":"JM Vilar","year":"2016","unstructured":"Vilar JM, Rubio M, Spinella G, Cuervo B, Sopena J, Cugat R, et al. Serum collagen type II cleavage epitope and serum hyaluronic acid as biomarkers for treatment monitoring of dogs with hip osteoarthritis. PLoS One. 2016;11(2):1\u201311.","journal-title":"PLoS One."},{"issue":"1","key":"3168_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cpr.12712","volume":"53","author":"W Jiang","year":"2020","unstructured":"Jiang W, Xu J. Immune modulation by mesenchymal stem cells. Cell Prolif. 2020;53(1):1\u201316.","journal-title":"Cell Prolif."},{"issue":"11","key":"3168_CR65","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.joca.2008.03.013","volume":"16","author":"LN Frost-Christensen","year":"2008","unstructured":"Frost-Christensen LN, Mastbergen SC, Vianen ME, Hartog A, DeGroot J, Voorhout G, et al. Degeneration, inflammation, regeneration, and pain\/disability in dogs following destabilization or articular cartilage grooving of the stifle joint. Osteoarthr Cartil. 2008;16(11):1327\u201335.","journal-title":"Osteoarthr Cartil."},{"key":"3168_CR66","unstructured":"Smith G, Myers SL, Brandt KD, Mickler EA, Albrecht ME. Effect of intraarticular hyaluronan injection on vertical ground reaction force and progression of osteoarthritis after anterior cruciate ligament transection. J Rheumatol. 2005;32(2):325-334."},{"issue":"9","key":"3168_CR67","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.joca.2011.06.007","volume":"19","author":"K Kuroki","year":"2011","unstructured":"Kuroki K, Cook CR, Cook JL. Subchondral bone changes in three different canine models of osteoarthritis. Osteoarthr Cartil. 2011;19(9):1142\u20139.","journal-title":"Osteoarthr Cartil."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03168-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-023-03168-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03168-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T22:03:32Z","timestamp":1730239412000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-023-03168-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3168"],"URL":"https:\/\/doi.org\/10.1186\/s13075-023-03168-7","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,3]]},"assertion":[{"value":"23 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This efficacy study (approval number EC: 2019_003), the biodistribution study (approval number EC: 2019_007), and the blood collection of the donor horses (approval number: EC_2018_002) were approved by an independent ethics committee approved by the Flemish government (recognition number: LA1700607). In addition, the Klifovet Animal Welfare Body evaluated the efficacy study and its procedures according to Directive 2010\/63\/EU (Klifovet Reg.-No: 18-08), concluding that the study could be conducted as planned. Both clinical studies were compliant with good clinical practices (VICH GL9), and all animal handlings were conducted according to European, national and regional animal welfare regulations (Directive 2001\/82\/EC as amended, Belgian animal welfare legislation (KB 29\/05\/2013), Directive 2010\/63\/EU, and EMEA\/CVMP\/816\/00-Final), and the principle of the 3Rs was applied. An informed consent was obtained for all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that this study was sponsored by Boehringer Ingelheim Veterinary Medicine Belgium (BIVMB) NV. The sponsor had the following involvement with the study: study design, data collection and analysis, decision to publish and preparation of the manuscript. CB, SB, ED, GP, LT, LVH and JHS are all employed by Boehringer Ingelheim or an affiliated company. JHS is an inventor of a pending patent covering the described immunomodulating technology owned by BIVMB (EP19162270.3). EDP, CB and JHS are the inventors of a patent covering the <sup>99m<\/sup>Tc labelling of ePB-MSCs owned by BIVMB (EP19200152.7). JHS, SB, GPA and CB are inventors of pending patent covering the mesenchymal stem cells for use in the treatment of osteoarthritis in animals owned by BIVMB (EP21184474.1). The content of this manuscript contains a stem cell product under development owned by BIVMB. GB and KH are employed by Klifovet AG. ND is the owner of a private veterinarian referral practice \u2018De Molenkreek\u2019. NV, TD are employed by Anacura. Other authors have no conflict of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"190"}}